Yep, would love to see HER-Vaxx licensed. I think it’s likely IMU spoke with Merck about licensing and IMU wanted a higher percentage of sales than what Merck were willing to offer, so it was decided IMU should run a combo with Keytruda, and if successful then a licensing deal would be signed at a higher percentage of sales… which wouldn’t be possible if IMU didn’t have the funds for it.
Ann: Share Purchase Plan Closing Date Extended, page-591
-
- There are more pages in this discussion • 110 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.4¢ |
Change
-0.004(5.88%) |
Mkt cap ! $499.7M | |||
| Open | High | Low | Value | Volume |
| 6.9¢ | 7.1¢ | 6.3¢ | $1.807M | 27.06M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 2002699 | 6.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.4¢ | 527618 | 8 |
View Market Depth
| Last trade - 11.29am 03/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |